• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human FBXL18 Polyclonal Antibody

The antibody against FBXL18 was raised in rabbit using the Human FBXL18 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, IHC.

ADC-53370A

The antibody against FBXL18 was raised in rabbit using the Human FBXL18 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, IHC.

$600.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-53370A ClonalityPolyclonal
Host SpeciesRabbitTarget NameFBXL18
Target SynonymsFBXL18 antibody; FBL18F-box/LRR-repeat protein 18 antibody; F-box and leucine-rich repeat protein 18 antibodyFormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, Avoid freeze / thaw cycles., PBS with 0.1% Sodium AzidePurification MethodAntigen affinity purified
ConjugateNon-conjugatedApplicationELISA, IHC
StorageUpon receipt

Immunogen Information


Immunogen DescriptionHuman FBXL18Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ96ME1
Background Information
  • Uniprot Id

    Q96ME1

  • Target Species

    Human

  • Target Name

    FBXL18

  • Target Full Name

    F-box/LRR-repeat protein 18

  • Target Function

    Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex.

  • Target Research Area

    Epigenetics and Nuclear Signaling

  • Target Synonyms

    FBXL18; FBL18F-box/LRR-repeat protein 18; F-box and leucine-rich repeat protein 18

Inquire Rabbit anti-Human FBXL18 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification